Aliceblue ANTInstall and trade smarter everywhere
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Krishna Institute of Medical Sciences Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Key metrics and details at a glance.
Price Band
₹825
Per ShareLot Size
18 Shares
Minimum Investment
₹14,850
Issue Size
₹2,120.18 Cr
Face Value
₹10
Per ShareIPO Type
Book Building
Retail Quota
10%
QIB Quota
75%
NII Quota
15%
Important dates for your applying strategy.
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
37.17%
Issue Type
Book Building
ISIN
INE967H01025
Krishna Institute of Medical Sciences Limited is one of the largest corporate healthcare groups, in AP and Telangana in terms of number of patients treated and treatments offered, according to the CRISIL Report commissioned by the Company. It provides multi-disciplinary integrated healthcare services in Tier 1, 2 and 3 cities, operating nine multi-specialty hospitals under the "KIMS Hospitals" brand, with an aggregate bed capacity of 3,064 beds including over 2,500 operational beds, as of March 31, 2021. It offers healthcare services across over 25 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother and child care.
The Indian healthcare delivery market is valued at Rs. 4.3 trillion and accommodated Rs. 1.7 billion treatments (both in-patient and outpatient) in Fiscal 2021. With renewed impetus from the PMJAY, the healthcare delivery market is expected to log a CAGR of 17-18% and reach Rs. 7.07 trillion in fiscal 2024. The share of IPD (in value terms) is expected to grow from 69% in the current fiscal to nearly 74% in Fiscal 2024, with OPD contributing the remaining. In terms of volumes, OPD is estimated to outweigh IPD volumes, with the latter contributing the bulk of the revenues to healthcare facilities.
Revenue, profit after tax and total assets across the last 3 reported financial years.
Amount in ₹ crore
How the company plans to utilize IPO proceeds.
The funds raised through this IPO will be used for:
Initial Public Offering of 25,997,133* equity shares of face value of Rs.10 each ("equity shares") of Krishna Institute of Medical Sciences Limited ("company" or "issuer") for cash at a price of Rs. 825^ per equity share (including a share premium of Rs. 815 per equity share) (the "offer price") aggregating to Rs. 2143.74 Crores (the "offer") comprising a fresh issue of 2,436,595* equity shares (including 254,777* equity shares to be issued under employee reservation portion at a price of Rs. 785 aggregating to Rs. 20 Crores) aggregating to Rs. 200^ Crores (the "fresh issue") and an offer for sale of 23,560,538* equity shares aggregating to Rs. 1943.74 Crores (the "offer for sale"), comprising 16,003,615* equity shares aggregating to Rs. 1320.30 Crores by General Atlantic Singapore kh Pte Ltd (the "investor Selling shareholder"), 387,966* equity shares aggregating to Rs. 32.01 Crores by Dr.Bhaskara Rao Bollineni, 775,933* equity shares aggregating to Rs. 64.01 Crores by Rajyasri Bollineni, 387,966* equity shares aggregating to Rs. 32.01 Crores by Bollineni Ramanaiah Memorial Hospitals Private Limited (collectively, the "promoter selling shareholders"), 6,005,058* equity shares aggregating to Rs. 495.42 Crores by persons referred to in annexure a (referred to as the "other Selling shareholders", together with the investor selling shareholder and promoter selling shareholders, the "selling shareholders", and such equity Shares the "offered shares"). The offer included a reservation of 254,777*^ equity shares, aggregating to Rs. 20 Crores (constituting 0.32% of the post-offer paid-up equity share capital), for subscription by eligible employees (the "employee reservation portion"). The offer less the employee reservation portion is hereinafter referred to as "net Offer". The offer and net offer constitutes 32.48% and 32.17% of the post-offer paid-up equity share capital of the company, respectively. The offer price is Rs. 825 per equity share and is 82.50 times the face value of the equity shares and the anchor investor offer price is Rs. 825 per equity share. * subject to finalisation of basis of allotment ^A discount of Rs. 40 per equity share was offered to eligible employees bidding in the employee reservation portion.
*Subject to approvals and market conditions.
Key competitive advantages and factors to consider before investing.
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Krishna Institute of Medical Sciences Limited was incorporated as `Jagjit Singh and Sons Private Limited', a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, Maharashtra at Mumbai on July 26, 1973. The Company changed the location of its registered office from the State of Maharashtra to the erstwhile State of Andhra Pradesh, pursuant to an order dated January 29, 2003 by the Company Law Board, Western Region Bench, Mumbai ("Order") and the registration of the Order vide certificate of registration dated February 21, 2003 by the Registrar of Companies, Andhra Pradesh and Telangana (then the Registrar of Companies, Andhra Pradesh) ("RoC"). Subsequently, the name of the Company was changed to `Krishna Institute of Medical Sciences Private Limited', pursuant to a letter of approval from the Central Government dated January 2, 2004 and a fresh certificate of incorporation issued by the RoC on January 2, 2004. Further, pursuant to the conversion of the Company to a public limited company, its name was changed to `Krishna Institute of Medical Sciences Limited' and the RoC issued a fresh certificate of incorporation on January 29, 2004.
Amount in ₹ crore
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.